The Court of Justice of the European Union held, for the first time, that a claim based on abuse of dominant position can be enforced within the pharmaceutical sector. Indeed, the pharmaceutical market was previously exempt from enforcement of this kind of claim in order to promote research and innovation. We publish the article written by Luca Ghedina and Lorenzo Gyulai published on the English web-based legal forum "Lexology".